Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Study Uncovers Healthcare Industry Trust and Knowledge Deficit Among Female Consumers

Women Are Healthcare Decision-Makers for Themselves and Others but Are Not Confident They Are Making Good Decisions NEW YORK, NY–(Marketwired – April 23, 2015) – Although women make the vast majority of healthcare decisions for themselves and others, 63 percent of women in the U.S., U.K., Germany, Japan, and Brazil lack confidence in the healthcare […]

Read More »

Publicis Touchpoint Solutions Announces Two New Executive Appointments

Tom Clark and Archie Robinson move into new leadership roles at Touchpoint Yardley, PA—April 21, 2015—Publicis Touchpoint Solutions, Inc—a leading provider of customized, omni-channel healthcare sales, service, and clinical teams—announced two executive appointments today. Tom Clark has been promoted into the role of executive vice president of business development, having formerly served as vice president of […]

Read More »

Palio Creative Leader Passes Torch To Distinguished Leadership Team

NEW YORK, NY – April 20, 2015 – PALIO, an inVentiv Health advertising agency that ignitesbold and beautifully disruptive ideas, announced today that Chief Creative Global Officer GuyMastrion has departed the agency. President Kim Johnson and Mastrion have worked over thepast year to chart the next phase of the agency’s evolution, including strengthening the executiveteam […]

Read More »

PARTNERS+simons President & CEO Named CEO of Myelin Health

BOSTON–(BUSINESS WIRE)–PARTNERS+simons, a 25-year old brand communications and integrated marketing services firm specializing in the healthcare and financial services industries, announced today that President and CEO Rich Levy has added responsibilities as the new CEO of Myelin Health. Rich will operate both as CEO of Myelin Health and president & CEO of PARTNERS+simons. Myelin Health, […]

Read More »

GlaxoSmithKline Recalls Flu Vaccine Over Potency Issues

U.K.-based GlaxoSmithKline (GSK) announced on April 14, 2015 that it was recalling all remaining lots of its 2014-2015 Flulaval Quadrivalent flu vaccine. The company noted that two of the components of the vaccine, the B strains, appeared to have lost potency below the minimum specifications. The potency issue, according to the company, the U.S. Centers […]

Read More »

Restrictive Drug Plan Regulations Will Hurt Patients

DALLAS, April 20, 2015 /PRNewswire-USNewswire/ — Increasing unnecessary regulations on drug plans could inflict higher costs on the 220 million Americans who get their medications through a managed drug plan, according to a  new report by National Center for Policy Analysis Senior Fellow Devon Herrick. “The degree to which drug benefit plans are managed efficiently […]

Read More »

Lupin Launches Zaxine in Canada

MUMBAI and MONTREAL, April 20, 2015 /PRNewswire/ — Zaxine 550mg (rifaximin) is a long term antibiotic treatment for adults living with hepatic encephalopathy (HE), a complication of liver disease (cirrhosis). HE can lead to a wide spectrum of mental and physical symptoms, including confusion, disruption in sleep patterns, personality changes and coma Zaxine® 550mg has approved by […]

Read More »

Personalization, privacy, and health – get ready for a shift

By Kent Groves, VP, client leadership group, Merkle Health For years, pharmaceutical marketers have observed rapidly shifting industry trends. To say that the agenda and role of the consumer is changing is an understatement, particularly as we see patients, caregivers, and healthcare professionals consuming and generating more digital media than ever before. The critical determination […]

Read More »

GlaxoSmithKline Sees Red at Design of Rival’s Purple Asthma Inhaler

GlaxoSmithKline (GSK) said Rowex Ltd is preparing to sell a product similar in its packaging to the “Seretide” inhaler and that this infringed its trademark. Seretide is the fourth-highest-selling pharmaceutical product in the world, with more than $62bn (€58bn) in global sales, including Ireland. The UK-based Glaxo Group, along with GSK (Ireland) Ltd, trading as […]

Read More »

AstraZeneca science is on the move, one year on from Pfizer bid

(Reuters) – Having seen off a hostile $118 billion bid launched a year ago by U.S. rival Pfizer, Anglo-Swedish company AstraZeneca is on the move — quite literally.  As of last month, a four-days-a-week service set up by the drugmaker with Sun Air is connecting staff in its new Cambridge science and operations hub with […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom